GO:0106433 O6-methyl-dGTP hydrolase activity

GO:0106433 O6-methyl-dGTP hydrolase activity is a molecular_function term that describes the enzymatic hydrolysis of O6-methyl-dGTP to O6-methyl-dGMP, diphosphate, and a proton. This activity is part of the cellular machinery that sanitizes the deoxynucleoside triphosphate (dNTP) pool, preventing the incorporation of damaged or methylated nucleotides into DNA. The reaction is chemically simple but biologically important because O6-methyl-dGTP can act as a mutagenic substrate if it is used by DNA polymerases. The best-characterized enzyme with this activity is MutT homologue 1 (MTH1, also known as NUDT1), which was shown to catalyze the hydrolysis of O6-methyl-dGTP. MTH1 belongs to the Nudix hydrolase family and is known for removing oxidized purine nucleotides from the dNTP pool; its ability to hydrolyze O6-methyl-dGTP extends its role to alkylation-derived nucleotide damage. Because O6-methylguanine adducts in DNA are mutagenic and their repair is nonuniform across the genome, the elimination of O6-methyl-dGTP by MTH1 provides a pre-replicative defense against alkylation-induced mutations. In addition, MTH1 can remove N6-methyl-dATP, indicating that the enzyme handles multiple methylated nucleotides and that this hydrolase activity is part of a wider nucleotide pool sanitation network. The O6-methyl-dGTP nucleotide itself has attracted interest in cancer research: a modified nucleoside O6-methyl-2'-deoxyguanosine-5'-triphosphate exhibits anti-glioblastoma activity in a caspase-independent manner, suggesting that this nucleotide and its metabolic handling can influence tumor cell survival. For researchers, GO:0106433 provides a precise annotation for experiments that measure the hydrolysis of O6-methyl-dGTP, for studies of MTH1 substrate specificity, and for investigations of how cells avoid alkylation-induced mutagenesis.

GO:0106433 O6-methyl-dGTP hydrolase activity is defined as the catalysis of the reaction O6-methyl-dGTP + H2O = O6-methyl-dGMP + diphosphate + H+. In other words, the enzyme uses water to cleave the triphosphate group of O6-methyl-dGTP, releasing O6-methyl-dGMP and diphosphate while producing a proton. This activity belongs to the molecular_function ontology aspect and is distinct from DNA repair glycosylases or methyltransferases because it acts on a free nucleotide rather than on DNA. The reaction removes a methylated nucleotide from the pool before it can be incorporated into DNA, thereby reducing the mutagenic burden of O6-methylguanine in the genome.

GO:0106433 O6-methyl-dGTP hydrolase activity is important because it protects cells from a mutagenic nucleotide that can be misincorporated into DNA. O6-methyl-dGTP is a methylated dNTP that, if used by DNA polymerases, can lead to O6-methylguanine in DNA, a lesion that is mutagenic and whose repair is nonuniform across the genome. MTH1 catalyzes the hydrolysis of O6-methyl-dGTP, thereby removing it from the dNTP pool and reducing the risk of mutation. This function places the activity within the broader field of nucleotide pool sanitation, which is critical for genome stability and is often dysregulated in cancer. In addition, the same nucleotide has been investigated for anti-glioblastoma activity, indicating that O6-methyl-dGTP metabolism can be exploited or targeted in cancer therapy. Therefore, understanding GO:0106433 helps researchers study mutagenesis, DNA repair, and potential therapeutic strategies that modulate nucleotide pools.

The following genes and proteins are directly or indirectly involved in O6-methyl-dGTP hydrolase activity, its regulation, or the metabolism of the substrate and related nucleotides.

MTH1 (NUDT1) expression and activity are regulated in response to cellular stress, and the enzyme is a target for small-molecule inhibitors in cancer research. The hydrolysis of O6-methyl-dGTP can be measured in vitro and is subject to competition from other substrates such as N6-methyl-dATP. Because MTH1 handles multiple substrates, its overall activity toward O6-methyl-dGTP may be influenced by the relative abundance of other nucleotides. Inhibitors of MTH1 could therefore modulate the removal of O6-methyl-dGTP and affect mutagenesis or cell survival.

MTH1 is often overexpressed in cancer cells, where it helps sanitize the dNTP pool and supports survival under oxidative and alkylation stress. The hydrolysis of O6-methyl-dGTP by MTH1 prevents the incorporation of a mutagenic nucleotide into DNA, thereby reducing mutations that could drive tumor progression. In glioblastoma, a modified nucleoside O6-methyl-2'-deoxyguanosine-5'-triphosphate exhibits anti-glioblastoma activity in a caspase-independent manner, linking this nucleotide to cancer cell death pathways. Therefore, GO:0106433 is relevant to cancer biology both as a protective activity and as a potential therapeutic target.

O6-methylguanine is a mutagenic lesion, and its repair is nonuniform across the genome, with some DNA regions being more interactive with O6-methylguanine than others. The presence of O6-methyl-dGTP in the nucleotide pool can lead to O6-methylguanine incorporation during replication, making its hydrolysis by MTH1 an important pre-replicative defense. Defects in this sanitation pathway could increase mutation load, especially in cells exposed to alkylating agents. Thus, GO:0106433 connects nucleotide pool metabolism to DNA repair and mutagenesis.

MTH1 is known to protect cells from oxidative stress by removing oxidized nucleotides, and its ability to hydrolyze methylated nucleotides such as O6-methyl-dGTP extends this protective role. In neurodegenerative contexts, oxidative stress can damage the nucleotide pool, and enzymes like MTH1 are part of the cellular defense. Although direct evidence for O6-methyl-dGTP in neurodegeneration is limited, the broader role of MTH1 in stress responses suggests that this activity contributes to neuronal survival.

Direct measurement of O6-methyl-dGTP hydrolysis can be performed using purified MTH1 and HPLC or mass spectrometry to detect O6-methyl-dGMP and diphosphate. Such assays are used to confirm substrate specificity and to test inhibitors.

Mass spectrometry-based nucleotide pool analysis can quantify O6-methyl-dGTP and related nucleotides in cells, providing evidence for the biological role of the hydrolase. This method is useful for comparing wild-type and MTH1-knockout cells.

Mutation frequency assays and DNA damage measurements can assess the consequences of O6-methyl-dGTP incorporation when MTH1 is absent or inhibited. These approaches link the enzymatic activity to genome stability.

Cell viability assays are used to study the anti-glioblastoma activity of O6-methyl-2'-deoxyguanosine-5'-triphosphate and the role of MTH1 in cell survival. Caspase-independent cell death can be monitored to understand the mechanism.

Researchers studying O6-methyl-dGTP hydrolase activity-related genes often need to determine whether a candidate gene is causally involved in nucleotide pool sanitation, mutagenesis, or cancer cell survival. EDITGENE provides CRISPR-based cell model services to support these investigations.

GO:0106433 O6-methyl-dGTP hydrolase activity is a molecular_function that removes the mutagenic nucleotide O6-methyl-dGTP from the dNTP pool, primarily through the action of MTH1 (NUDT1). This activity protects genome integrity by preventing the incorporation of O6-methylguanine into DNA, a lesion whose repair is nonuniform. MTH1 also handles other methylated nucleotides such as N6-methyl-dATP, highlighting its broader role in nucleotide sanitation. The link between O6-methyl-dGTP and anti-glioblastoma activity further underscores the biomedical relevance of this pathway. Researchers can use CRISPR-based models to dissect the function of MTH1 and related genes in health and disease.